Clinical Trial Update: Dihydroartemisinin- Piperaquine Versus Artemether- Lumefantrine in the Treatment Uncomplicated Plasmodium Falciparum Malaria in Sudan [Phase 4]

View source ↗

Summary

This clinical trial update compares dihydroartemisinin-piperaquine with artemether-lumefantrine for treating uncomplicated Plasmodium falciparum malaria in Suda…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plasmodium Falciparum Malaria

Drugs mentioned

• Artemether-lumefantrine (artemether and lumefantrine)
• Dihydroartemisinin-piperaquine (dihydroartemisinin-piperaquine)

Snippet

Sponsor: University of Khartoum | Conditions: Malaria | Phase 4 | Status: UNKNOWN